Chemoradiation of pancreatic carcinoma
Pancreatic carcinoma is a malignancy with a poor prognosis and the 4th. most common cause of cancer-related deaths. Patients are usually diagnosed at advanced stage of the disease. Surgical resection remains the only potentially curative therapy, as only 20% of the patients present with disease are...
Main Authors: | Erdinç Nayır, Ekin Ermis |
---|---|
Format: | Article |
Language: | English |
Published: |
Turkiye Klinikleri
2016-08-01
|
Series: | Journal of Oncological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452336416300048 |
Similar Items
-
Adjuvant Chemo-Radiotherapy versus Chemotherapy in Pancreatic Carcinoma
by: Shimaa Attia, et al.
Published: (2017-06-01) -
Long‐term survival after surgery of pancreatic primary squamous cell carcinoma: A case report and literature review
by: Abdelkader Taibi, et al.
Published: (2019-11-01) -
External Validation of a Nomogram to Predict Survival and Benefit of Concurrent Chemoradiation for Stage II Nasopharyngeal Carcinoma
by: Pui-Lam Yip, et al.
Published: (2021-08-01) -
Chemoradiation for Olfactory Neuroblastoma
by: Sheun-Ru Yang, et al.
Published: (2015-03-01) -
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival
by: Alessio G. Morganti, et al.
Published: (2019-06-01)